权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Translational Studies of Age-Associated Arterial Dysfunction, Western Diet and Aerobic Exercise: Role of the Gut Microbiome

年龄相关动脉功能障碍、西方饮食和有氧运动的转化研究：肠道微生物组的作用

基本信息

批准号：
9216189
负责人：
DOUGLAS R SEALS
金额：
$ 76.55万
依托单位：
UNIVERSITY OF COLORADO
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-01-01 至 2020-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9216189
关键词：
Adipose tissue Adult Aerobic Exercise Affect Age Aging Antibiotic Therapy Arteries Atherosclerosis Bacteria Biological Blood Circulation Blood Vessels Cardiovascular Diseases Characteristics Chronic Collection Consumption Coupled Cross-Over Studies Development Diet Disease Elderly Environmental Risk Factor Event Exercise Fatty acid glycerol esters Fiber Functional disorder Germ-Free Goals Health Human Human Microbiome Impairment Inflammation Inflammatory Intestines Investigation Knock-out Laboratories Life Life Style Link Longevity Mediating Mediator of activation protein Metabolic Microbe Modeling Modernization Molecular Morbidity - disease rate Mus Nutrient Oxidative Stress Pathway interactions Permeability Pharmacology Phenotype Physical activity Physiological Processes Plasma Publishing Randomized Research Research Design Research Technics Risk Role Signal Pathway Signal Transduction Single-Blind Study Societies TLR4 gene Taxonomy Time Translational Research Transplantation Work age effect age related arterial stiffness cardiovascular disorder risk cardiovascular risk factor density diet and exercise endothelial dysfunction feeding functional decline gut microbiome gut microbiota humanized mouse innovation insight lifestyle factors metabolomics microbial microbiome microbiota mortality new therapeutic target novel particle prevent sugar therapeutic target translational approach translational study trimethyloxamine western diet

项目摘要

Project Summary Age-related arterial dysfunction is the main risk factor for cardiovascular diseases (CVD). Recently, we have used short-term and lifelong studies in mice to determine how a Western-style diet (WD; high fat and sugar, low fiber and nutrient density) and aerobic exercise (EX), common lifestyle factors, interact with aging to influence endothelial dysfunction and stiffening of the large elastic arteries. We found that WD accelerates, and EX prevents, these key features of arterial aging via changes in oxidative stress and inflammation. The gut microbiome is a strong modulator of host metabolic health and inflammation that is influenced by age, diet and EX, but there is no information about its effects on arterial function in these or other settings. Our integrative hypothesis is that dysregulation of the gut microbiome (gut dysbiosis) with primary aging and WD consumption, coupled with increased intestinal permeability that allows gut-derived particles to leak into circulation, may act to impair arterial function via changes to adverse gut-derived metabolites such as atherosclerosis-linked trimethylamine-N-oxide (TMAO), and stimulation of toll-like receptor 4-induced pro- inflammatory signaling, whereas chronic aerobic exercise protects against these effects. The purpose of this application is to determine the potential causal role of the gut microbiome in the effects of aging, WD and EX on arterial function, and gain insight into the underlying metabolomic and inflammatory mechanisms. We will employ 3 highly innovative, complementary translational approaches: 1. Mouse studies that allow us to discern cause-and-effect: a) by assessing arterial function with aging ± WD in the presence vs. absence of the gut microbiome and associated signaling; and b) by determining if vascular phenotypes associated with aging, WD and EX can be transferred via the gut microbiome. We also will explore possible mechanisms using pharmacological inhibition and/or knock-out of suspected pathways. 2. Human studies assessing the time course (temporal associations) of diet (WD vs. non-WD)-induced changes in the gut microbiome vs. arterial function in young and older exercising and non-exercising healthy adults, using a randomized, single-blind, controlled feeding crossover study design. 3. Combined mouse/human studies employing “humanized” mice to determine if the characteristics present in the human gut microbiome with age, WD and EX predictably influence arterial function. These studies will determine not only changes to gut microbe presence and relative abundance with aging, WD and EX, but also the functional effects of those changes, allowing us to gain novel insight into the role of the gut microbiome in modulating vascular function with aging and these common lifestyle influences. The expected results have the potential to establish the gut microbiome as a key mechanism and therapeutic target for age-related arterial dysfunction, and to identify lifestyle or pharmacological strategies that may preserve microbial health, enhance arterial function and reduce the risk of age-related CVD.